BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 29329780)

  • 1. Oncogenic RAC1 and NRAS drive resistance to endoplasmic reticulum stress through MEK/ERK signalling.
    Bright MD; Clarke PA; Workman P; Davies FE
    Cell Signal; 2018 Apr; 44():127-137. PubMed ID: 29329780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRAF Inhibitors Amplify the Proapoptotic Activity of MEK Inhibitors by Inducing ER Stress in NRAS-Mutant Melanoma.
    Niessner H; Sinnberg T; Kosnopfel C; Smalley KSM; Beck D; Praetorius C; Mai M; Beissert S; Kulms D; Schaller M; Garbe C; Flaherty KT; Westphal D; Wanke I; Meier F
    Clin Cancer Res; 2017 Oct; 23(20):6203-6214. PubMed ID: 28724666
    [No Abstract]   [Full Text] [Related]  

  • 3. Oncogenic activation of MEK/ERK primes melanoma cells for adaptation to endoplasmic reticulum stress.
    Croft A; Tay KH; Boyd SC; Guo ST; Jiang CC; Lai F; Tseng HY; Jin L; Rizos H; Hersey P; Zhang XD
    J Invest Dermatol; 2014 Feb; 134(2):488-497. PubMed ID: 23921951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging of single cell responses to ER stress indicates that the relative dynamics of IRE1/XBP1 and PERK/ATF4 signalling rather than a switch between signalling branches determine cell survival.
    Walter F; Schmid J; Düssmann H; Concannon CG; Prehn JH
    Cell Death Differ; 2015 Sep; 22(9):1502-16. PubMed ID: 25633195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-talk between PI3K/Akt and MEK/ERK pathways mediates endoplasmic reticulum stress-induced cell cycle progression and cell death in human hepatocellular carcinoma cells.
    Dai R; Chen R; Li H
    Int J Oncol; 2009 Jun; 34(6):1749-57. PubMed ID: 19424594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crosstalk between PI3 kinase/PDK1/Akt/Rac1 and Ras/Raf/MEK/ERK pathways downstream PDGF receptor.
    Niba ET; Nagaya H; Kanno T; Tsuchiya A; Gotoh A; Tabata C; Kuribayashi K; Nakano T; Nishizaki T
    Cell Physiol Biochem; 2013; 31(6):905-13. PubMed ID: 23817184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nuclear receptor peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) promotes oncogene-induced cellular senescence through repression of endoplasmic reticulum stress.
    Zhu B; Ferry CH; Markell LK; Blazanin N; Glick AB; Gonzalez FJ; Peters JM
    J Biol Chem; 2014 Jul; 289(29):20102-19. PubMed ID: 24898257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Akt-1 mediates survival of chondrocytes from endoplasmic reticulum-induced stress.
    Price J; Zaidi AK; Bohensky J; Srinivas V; Shapiro IM; Ali H
    J Cell Physiol; 2010 Mar; 222(3):502-8. PubMed ID: 20020442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activating
    Shirazi F; Jones RJ; Singh RK; Zou J; Kuiatse I; Berkova Z; Wang H; Lee HC; Hong S; Dick L; Chattopadhyay N; Orlowski RZ
    Proc Natl Acad Sci U S A; 2020 Aug; 117(33):20004-20014. PubMed ID: 32747568
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of mitogen-activated protein kinase signaling pathway sensitizes breast cancer cells to endoplasmic reticulum stress-induced apoptosis.
    Yang F; Tang XY; Liu H; Jiang ZW
    Oncol Rep; 2016 Apr; 35(4):2113-20. PubMed ID: 26796921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Unfolded Protein Response: A Novel Therapeutic Target for Poor Prognostic
    Forsythe N; Refaat A; Javadi A; Khawaja H; Weir JA; Emam H; Allen WL; Burkamp F; Popovici V; Jithesh PV; Isella C; Labonte MJ; Mills IG; Johnston PG; Van Schaeybroeck S
    Mol Cancer Ther; 2018 Jun; 17(6):1280-1290. PubMed ID: 29483217
    [No Abstract]   [Full Text] [Related]  

  • 12. Rac1 and RhoG promote cell survival by the activation of PI3K and Akt, independently of their ability to stimulate JNK and NF-kappaB.
    Murga C; Zohar M; Teramoto H; Gutkind JS
    Oncogene; 2002 Jan; 21(2):207-16. PubMed ID: 11803464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cross-talk between PI3K/Akt and MEK/ERK pathways regulates human hepatocellular carcinoma cell cycle progression under endoplasmic reticulum stress].
    Yan DM; Dai RY; Duan CY; Chen SK; Liu YP; Chen CN; Li H
    Zhonghua Gan Zang Bing Za Zhi; 2010 Dec; 18(12):909-14. PubMed ID: 21205476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyruvate kinase M1 interacts with A-Raf and inhibits endoplasmic reticulum stress-induced apoptosis by activating MEK1/ERK pathway in mouse insulinoma cells.
    Horiuchi Y; Nakatsu D; Kano F; Murata M
    Cell Signal; 2017 Oct; 38():212-222. PubMed ID: 28743549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory cross-talk between the AMPK and ERK pathways mediates endoplasmic reticulum stress-induced insulin resistance in skeletal muscle.
    Hwang SL; Jeong YT; Li X; Kim YD; Lu Y; Chang YC; Lee IK; Chang HW
    Br J Pharmacol; 2013 May; 169(1):69-81. PubMed ID: 23373714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translational and posttranslational regulation of XIAP by eIF2α and ATF4 promotes ER stress-induced cell death during the unfolded protein response.
    Hiramatsu N; Messah C; Han J; LaVail MM; Kaufman RJ; Lin JH
    Mol Biol Cell; 2014 May; 25(9):1411-20. PubMed ID: 24623724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of CHOP/GADD153 during coronavirus infectious bronchitis virus infection modulates apoptosis by restricting activation of the extracellular signal-regulated kinase pathway.
    Liao Y; Fung TS; Huang M; Fang SG; Zhong Y; Liu DX
    J Virol; 2013 Jul; 87(14):8124-34. PubMed ID: 23678184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TMEM33: a new stress-inducible endoplasmic reticulum transmembrane protein and modulator of the unfolded protein response signaling.
    Sakabe I; Hu R; Jin L; Clarke R; Kasid UN
    Breast Cancer Res Treat; 2015 Sep; 153(2):285-97. PubMed ID: 26268696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective, potent blockade of the IRE1 and ATF6 pathways by 4-phenylbutyric acid analogues.
    Zhang H; Nakajima S; Kato H; Gu L; Yoshitomi T; Nagai K; Shinmori H; Kokubo S; Kitamura M
    Br J Pharmacol; 2013 Oct; 170(4):822-34. PubMed ID: 23869584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ran is a potential therapeutic target for cancer cells with molecular changes associated with activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK pathways.
    Yuen HF; Chan KK; Grills C; Murray JT; Platt-Higgins A; Eldin OS; O'Byrne K; Janne P; Fennell DA; Johnston PG; Rudland PS; El-Tanani M
    Clin Cancer Res; 2012 Jan; 18(2):380-91. PubMed ID: 22090358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.